BPMC
Blueprint Medicines Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +16.7% ·
aandelenstroom +9.4% ·
netto nieuwe posities +14.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2025 | 18 | +4 | 21.31M | $2.73B | +5 | −1 |
| Q1 2025 | 11 | -3 | 14.87M | $1.32B | — | −3 |
| Q4 2024 | 14 | +2 | 17.34M | $1.51B | +2 | — |
| Q3 2024 | 11 | -1 | 13.35M | $1.23B | — | −1 |
| Q2 2024 | 12 | — | 13.51M | $1.46B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.68M | +5.4% | $495.33M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.68M | +5.4% | $495.33M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 4.28M | +8.0% | $373.42M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 11 | State Street Global Advisors ✦ (passief) | 2.50M | — | $218.07M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 1.49M | +0.7% | $130.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.49M | +0.7% | $130.00M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 737.36K | +19.2% | $64.31M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | Norges Bank ✦ (passief) | 711.16K | +17.9% | $62.03M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 649.96K | +734.8% | $56.69M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 649.96K | +734.8% | $56.69M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 361.80K | +41.5% | $31.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 361.80K | +41.5% | $31.56M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 323.04K | -3.7% | $28.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 166.42K | Nieuw | $14.52M | 0.0% | New | 1 | SEC ↗ |
| 22 | Marshall Wace ✦ | 161.88K | -51.5% | $14.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Marshall Wace ✦ | 161.88K | -51.5% | $14.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Marshall Wace ✦ | 161.88K | -51.5% | $14.12M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 144.69K | +26.9% | $12.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 144.69K | +26.9% | $12.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 144.69K | +26.9% | $12.62M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | Renaissance Technologies ✦ | 126.30K | -27.6% | $11.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Gotham Asset Management ✦ | 3.54K | Nieuw | $309,195 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $14.52M | 0.0% |
| Gotham Asset Management | $309,195 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 2 houders, 301 aandelen, $38,583 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.